Safety perspectives on presently considered drugs for the treatment of COVID-19.
Penman SL, Kiy RT, Jensen RL, Beoku-Betts C, Alfirevic A, Back D, Khoo SH, Owen A, Pirmohamed M, Park BK, Meng X, Goldring CE, Chadwick AE.
Penman SL, et al. Among authors: park bk.
Br J Pharmacol. 2020 Oct;177(19):4353-4374. doi: 10.1111/bph.15204. Epub 2020 Aug 13.
Br J Pharmacol. 2020.
PMID: 32681537
Free PMC article.
Review.